Search
for
Sort by
Research 91–120 of 1000+
- Lupus erythematosus: systemic and cutaneous manifestations
- Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management
- THE DISEASE SPECTRUM, EPIDEMIOLOGY, AND ETIOLOGY OF TOXIC-SHOCK SYNDROME
- Comparison of cutaneous manifestations in chronic kidney disease with or without dialysis
- ANIFROLUMAB IN THE MANAGEMENT OF LUPUS HEADACHES: A CASE REPORT
- MIXED CONNECTIVE TISSUE DISEASE EVOLVING FROM THE SEQUENTIAL OVERLAP OF SYSTEMIC LUPUS ERYTHEMATOSUS, SJÖGREN’S SYNDROME, RHEUMATOID ARTHRITIS AND DERMATOMYOSITIS: A FOLLOW-UP
- Treating Psoriasis: What Is New About Fumaric Acid Esters?
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- The Clinical Presentation of Systemic Lupus Erythematosus
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Skin disorders associated with the COVID‐19 pandemic: A review
- Symptom management in inflammatory bowel disease
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- NAD⁺ Biology in Ageing and Chronic Disease: Mechanisms and Evidence across Skin, Fertility, Osteoarthritis, Hearing and Vision Loss, Gut Health, Cardiovascular–Hepatic Metabolism, Neurological Disorders, and Muscle
- A Rare Case of Antinuclear Antibody-Negative Systemic Lupus Erythematosus Presenting With Generalized Lymphadenopathy as the Initial Manifestation
- Fever and rash as initial signs of systemic autoimmune disease. Case Report.
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment
- Generalized pustular psoriasis responsive to PUVA and oral cyclosporin therapy
- Tertiary hypothyroidism in a dog
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
- Abrocitinib in the Treatment of Severe Alopecia Areata in a Pediatric Patient: A Case Report
- Letters: CD4+ Lymphocytopenia in Systemic Lupus Erythematosus
- Identification of an Intronic Regulatory Element Necessary for Tissue-Specific Expression of <i>Foxn1</i> in Thymic Epithelial Cells
- Alopecia Universalis Occurring after Alemtuzumab Treatment for Multiple Sclerosis. A Two-Year Follow-Up of Two Patients
- Trichothiodystrophy
- Multisystem Inflammatory Syndrome in Adults (MIS-A) and SARS-CoV2: An Evolving Relationship
- Association between Mesenchymal Stem Cells and COVID-19 Therapy: Systematic Review and Current Trends
- Genetic Ablation of the <i>CDP/Cux</i> Protein C Terminus Results in Hair Cycle Defects and Reduced Male Fertility
- Case of alemtuzumab-related alopecia areata management in MS
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies